<DOC>
	<DOCNO>NCT02746471</DOCNO>
	<brief_summary>The Reveal LINQ Registry generate reliable long-term `` real world '' data product performance , economic valuation , site-of-service procedural information .</brief_summary>
	<brief_title>Reveal LINQ Registry</brief_title>
	<detailed_description>The study prospective , non-randomized , observational , multi-center , global study . The study characterize clinical action initiate Reveal LINQ arrhythmia detection estimate procedure-related acute infection rate . Approximately 1,500 subject implant Reveal LINQ ICM undergo continuous remote monitoring follow prospectively insertion 18 month .</detailed_description>
	<mesh_term>Arrhythmias , Cardiac</mesh_term>
	<criteria>Subject legally authorize representative provide write authorization and/or consent per institution geographical requirement . Subject intend receive treat Reveal LINQ ICM insert next 30 day . Patient enrol date insertion Reveal LINQ ICM Subject consent prior ICM insertion Subject , expect inaccessible followup Subject exclusion criterion require local law Subject currently enrol plan enroll concurrent study may confound result study . Coenrollment concurrent drug and/or device clinical study ( include registry ) require approval study manager designee .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>